Moderna
MRNA
#276
Rank
A$125.13 B
Marketcap
A$309.28
Share price
3.43%
Change (1 day)
730.11%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -A$4.46 Billion

According to Moderna 's latest financial reports the company's current earnings are A$2.21 Billion. In 2025 the company made an earning of -A$4.14 Billion, an increase over its 2024 earnings that were of -A$5.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$4.46 Billion7.6%
2025 -A$4.14 Billion-23.03%
2024 -A$5.38 Billion-8.22%
2023 -A$5.86 Billion-140.65%
2022 A$14.40 B-27.81%
2021 A$19.95 B-1911.15%
2020 -A$1.11 Billion44.7%
2019 -A$0.77 Billion28.63%
2018 -A$0.6 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.08 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.96 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$10.08 B-320.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-A$71.15 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$62.65 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.83 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-A$0.24 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA